3 studies found for: Open Studies | Waldenström’s Macroglobulinemia | Phase 3
Efficacy of First Line DRC +/- Bortezomib for Patients With Waldenström's Macroglobulinemia
A Study Comparing BGB-3111 and Ibrutinib in Subjects With Waldenström's Macroglobulinemia (WM)
Efficacy and Safety of Ibrutinib in Patients With CLL and Other Indolent B-cell Lymphomas Who Are Chronic Hepatitis B Virus Carriers or Occult Hepatitis B Virus Carriers
† Study has passed its completion date and status has not been verified in more than two years.